DICE Therapeutics, Inc.

NasdaqGM:DICE Stock Report

Mkt Cap: US$1.5b

DICE Therapeutics Future Growth

How is DICE Therapeutics forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


-21.9%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGM:DICE - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2025N/A-214-190-1694
12/31/2024N/A-170-148-1294
12/31/2023N/A-129-117-1135
9/30/2022N/A-77-63-61N/A
6/30/2022N/A-74-56-54N/A
3/31/20221-59-46-45N/A
12/31/20211-49-40-39N/A
9/30/20211-40-31-30N/A
6/30/20212-29-27-27N/A
3/31/20211-27-24-24N/A
12/31/20201-24-21-21N/A
12/31/20196-13-17-16N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: DICE is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: DICE is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: DICE is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: DICE is forecast to have no revenue next year.

High Growth Revenue: DICE is forecast to have no revenue next year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if DICE's Return on Equity is forecast to be high in 3 years time


Discover growth companies